Successful Treatment of Generalized Essential Telangiectasia with 6-Mercaptopurine
Glazer, A.M.; Sofen, B.D.; Rigel, D.S.; Shupack, J.L.
Journal of Drugs in Dermatology Jdd 16(3): 280-282
2017
ISSN/ISBN: 1545-9616 PMID: 28301625 Document Number: 17249
Generalized essential telangiectasia (GET) is a notoriously difficult to treat disorder with no current satisfactory treatments. This case and discussion report the use of 6-mercaptopurine (6-MP) as a successful treatment for GET. Moreover, we show that GET may represent a state of increased angiogenesis, a paradigm shift from the current understanding that these telangiectasias represent dilatations of only pre-existing vessels. This new view of GET may drive others to look at novel agents for treatment.
Document emailed within 1 workday
